FDA Inspection
OsteoLife Biomedical, LLCOsteoLife Biomedical, LLC – FDA Inspection, Mar 26, 2015
Record Details
This FDA Inspection record concerns OsteoLife Biomedical, LLC, with an inspection on March 26, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- OsteoLife Biomedical, LLC
- Inspection Date
- March 26, 2015
- Product Type
- Biologics
View Company Profile
ID · acec07b0-9a20-4901-b94e-aa62168445ad
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 919494
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.260(e)Storage temperatures recorded, maintained
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OsteoLife Biomedical, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 11, 2024 | Not classified | Florida District Office | |
| October 18, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 15, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for OsteoLife Biomedical, LLC
- FDA Inspection 1256937 - 2024-12-11
- FDA Inspection 1111921 - 2019-10-18
- FDA Inspection 1028926 - 2017-08-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.